Cargando…
Adapting patient treatment of neurological diseases during the COVID-19 pandemic
Treating neurological patients during the pandemic period has become extremely challenging. At the same time, responding properly to these challenges has been diverse around the world, with varying levels of readiness, discipline, and approach. Additionally, there are significant differences in heal...
Autor principal: | Mendoza, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIMS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323254/ https://www.ncbi.nlm.nih.gov/pubmed/37426782 http://dx.doi.org/10.3934/Neuroscience.2023006 |
Ejemplares similares
-
Neurological manifestations of COVID-19: with emphasis on Iranian patients
por: Aslan, Cynthia, et al.
Publicado: (2021) -
Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19
por: Puccioni-Sohler, Marzia, et al.
Publicado: (2020) -
Applications of nanomaterials in COVID-19 pandemic
por: Xiao, Mei-Fang, et al.
Publicado: (2021) -
Dock protein family in brain development and neurological disease
por: Shi, Lei
Publicado: (2013) -
Chronic quaternary ammonium compound exposure during the COVID-19 pandemic and the impact on human health
por: Frantz, Aubrey L.
Publicado: (2023)